News

Company news & press releases.

$1.5M Seed Round Closed - Press Release, April 2026

ScopeSys closes CAD$1.5M seed round financing to launch its first benchtop analytics system for genetic medicines development. The round was backed by Canadian and US investors and will accelerate the commercial launch of the ScopeTop™ instrument and LNP-specific consumable, and scale the company’s analytical services for genomic researchers worldwide.

View Press Release

Leadership Appointments - Press Release, November 2025

Learn about ScopeSys' latest leadership appointments, Padma Kodukula as CEO and James Taylor as Chairman of the Board, as the company scales from platform validation to commercial launch. This new leadership team will guide the development and commercialization of ScopeSys' single-molecule analytics platform, leveraging instruments and services that accelerate the path to next-generation medicines.

View Press Release